DiaMedica Therapeutics Inc. (DMAC)

NASDAQ: DMAC · IEX Real-Time Price · USD

3.640

-0.050 (-1.36%)

At close: Jul 26, 2024, 4:00 PM

3.510

-0.130 (-3.57%)

After-hours: Jul 26, 2024, 5:55 PM EDT

DiaMedica Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Selling, General & Admin	8.32	8.16	6.16	4.88	4.49	3.69	Upgrade
Research & Development	13.17	13.11	7.84	8.77	8.21	7.9	Upgrade
Operating Expenses	21.49	21.27	14	13.65	12.7	11.59	Upgrade
Operating Income	-21.49	-21.27	-14	-13.65	-12.7	-11.59	Upgrade
Interest & Investment Income	1.93	1.93	0.35	-	-	-	Upgrade
Other Non Operating Income (Expenses)	0.34	-	-	0.08	0.43	0.98	Upgrade
EBT Excluding Unusual Items	-19.22	-19.34	-13.65	-13.56	-12.27	-10.62	Upgrade
Pretax Income	-19.22	-19.34	-13.65	-13.56	-12.27	-10.62	Upgrade
Income Tax Expense	0.04	0.04	0.03	0.03	0.03	0.03	Upgrade
Net Income	-19.26	-19.38	-13.68	-13.59	-12.29	-10.65	Upgrade
Net Income to Common	-19.26	-19.38	-13.68	-13.59	-12.29	-10.65	Upgrade
Shares Outstanding (Basic)	35	33	26	21	16	12	Upgrade
Shares Outstanding (Diluted)	35	33	26	21	16	12	Upgrade
Shares Change (YoY)	34.03%	23.16%	27.29%	32.48%	30.80%	54.81%	Upgrade
EPS (Basic)	-0.54	-0.60	-0.52	-0.65	-0.78	-0.89	Upgrade
EPS (Diluted)	-0.54	-0.60	-0.52	-0.65	-0.78	-0.89	Upgrade
Free Cash Flow	-20.32	-18.75	-11.59	-12.27	-9.23	-9.1	Upgrade
Free Cash Flow Per Share	-0.57	-0.58	-0.44	-0.59	-0.59	-0.76	Upgrade
EBITDA	-21.46	-21.24	-13.98	-13.62	-12.68	-11.57	Upgrade
D&A For EBITDA	0.03	0.03	0.03	0.02	0.02	0.02	Upgrade
EBIT	-21.49	-21.27	-14	-13.65	-12.7	-11.59	Upgrade

Source: S&P Capital IQ. Standard template.